PKI (14-24)amide TFA is an amidated inhibitory peptide segment used to evaluate kinase-regulation motifs. Its sequence supports conformational alignment with catalytic regions. Hydrophobic residues enhance binding studies. Researchers use it in mechanistic exploration of kinase-inhibitory domains.
CAT No: A40017
CAS No:1293946-39-0
Synonyms/Alias:PKI (14-24)amide TFA;1293946-39-0;PKI (14-24)amide (TFA);HY-P3929A;DA-66767;CS-0652891;
3. Cationic cell-penetrating peptides are potent furin inhibitors
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.